Which has grown faster, BNTX or UTHR?

Over the past five years, UTHR grew revenue faster — BNTX at a 2.16% CAGR versus UTHR at 16.05%.

Is BNTX or UTHR more profitable?

UTHR runs the higher net margin — BNTX at -44.73% versus UTHR at 40.61%.

Which has been the better investment, BNTX or UTHR?

Over the past 5-year, UTHR delivered the higher annualized total return — BNTX at -17.39% versus UTHR at 17.22%. Past performance doesn't predict future results.

BioNTech SE (BNTX) vs United Therapeutics Corporation (UTHR)

UTHR leads on 7 of 10 compared metrics.

A side-by-side comparison of BioNTech SE and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

United Therapeutics Corporation

$23.17B

$545.96Healthcare

Total return — BNTX vs UTHR

growth of $100 · last 7y

BNTX +535.8%UTHR +576.1%UTHR compounded faster

BNTX UTHR

BNTX vs UTHR: by the numbers

•UTHR is the larger company ($23.17B vs $22.90B market cap).
•UTHR is profitable (40.61% net margin) while BNTX runs a net loss (-44.73%).
•UTHR grew revenue faster over the past five years (16.05% vs 2.16% CAGR).

Which is better, BNTX or UTHR?

Metric tally: BNTX 3 · UTHR 7

It depends on what you're optimizing for:

GrowthUTHR(faster 5Y revenue CAGR)

QualityUTHR(higher ROIC)

Valuation

Metric	BNTX	UTHR
P/E ratio	—	20.18
Forward P/E	—	16.48
P/S ratio	6.97●	8.13
P/B ratio	1.06●	4.37
PEG ratio	—	1.16
EV / EBITDA	—	14.41
FCF yield	6.53%●	3.95%

Profitability

Metric	BNTX	UTHR
Gross margin	73.26%	86.58%●
Operating margin	-51.55%	45.34%●
Net margin	-44.73%	40.61%●
ROE	-6.79%	21.82%●
ROIC	-3.14%	16.14%●

Growth (annualized)

Metric	BNTX	UTHR
Revenue CAGR (5Y)	2.16%	16.05%●
EPS CAGR (5Y)	—	20.93%
FCF CAGR (5Y)	—	12.12%
Total return CAGR (5Y)	-17.39%	24.96%●

Frequently asked

Which is better, BNTX or UTHR?: It depends on your goal. growth: UTHR (faster 5Y revenue CAGR); quality: UTHR (higher ROIC). Across all compared metrics, UTHR leads 7 to 3.
Which has grown faster, BNTX or UTHR?: Over the past five years, UTHR grew revenue faster — BNTX at a 2.16% CAGR versus UTHR at 16.05%.
Is BNTX or UTHR more profitable?: UTHR runs the higher net margin — BNTX at -44.73% versus UTHR at 40.61%.
Which has been the better investment, BNTX or UTHR?: Over the past 5-year, UTHR delivered the higher annualized total return — BNTX at -17.39% versus UTHR at 17.22%. Past performance doesn't predict future results.

Go deeper

Full BNTX analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

BioNTech SE P/E ratio United Therapeutics P/E ratio BioNTech SE dividend yield United Therapeutics dividend yield BioNTech SE ROE United Therapeutics ROE BioNTech SE operating margin United Therapeutics operating margin BioNTech SE revenue growth United Therapeutics revenue growth BioNTech SE free cash flow United Therapeutics free cash flow

BioNTech SE & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.